Hydrolyzed Collagen Supplement Firm Agrees To Order Barring Claims To Grow Bone, Cartilage

Claims of bone and cartilage growth, along with relief of joint pain, shot down by FTC. But company says claims “are adequately substantiated by existing studies and scientific literature.”

• Source: Shutterstock

The Federal Trade Commission settles a complaint against ZyCal Bioceuticals Healthcare Company Inc. about claims that its Ostinol hydrolyzed collagen dietary supplements grow bone and cartilage to relieve joint pain.

More from Legal

More from Policy & Regulation